Lumexa Imaging (NASDAQ:LMRI) Stock Price Down 7.6% - What's Next?

Key Points

• Lumexa Imaging shares fell 7.6% to $11.7550 on Friday, trading 232,062 shares (down 64% from average) and remaining below its 50‑day moving average of $13.90.
• Raymond James upgraded the stock to a "strong‑buy" with a $23 price target, and the consensus rating shown is a Strong Buy with a $23.00 target.
• Notable institutional buying has emerged, with new stakes reported from firms including Goldman Sachs (~$18.87M) and Seven Grand Managers (~$11.94M), indicating significant investor interest despite the pullback.

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI - Get Free Report) traded down 7.6% on Friday . The company traded as low as $11.75 and last traded at $11.7550. 232,062 shares changed hands during trading, a decline of 64% from the average session volume of 637,964 shares. The stock had previously closed at $12.72.

Analyst Upgrades and Downgrades

Separately, Raymond James Financial raised Lumexa Imaging from an "outperform" rating to a "strong-buy" rating and set a $23.00 target price for the company in a research note on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the company currently has an average rating of "Strong Buy" and a consensus price target of $23.00.

Lumexa Imaging Trading Down 7.9%

The stock's fifty day moving average price is $13.90.

Institutional Investors Weigh In On Lumexa Imaging

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Assetmark Inc. purchased a new position in shares of Lumexa Imaging during the 4th quarter worth $36,000. Geode Capital Management LLC acquired a new position in Lumexa Imaging in the fourth quarter valued at about $1,548,000. Seven Grand Managers LLC purchased a new position in Lumexa Imaging during the fourth quarter worth about $11,942,000. Goldman Sachs Group Inc. acquired a new stake in shares of Lumexa Imaging during the fourth quarter valued at about $18,870,000. Finally, TD Asset Management Inc acquired a new stake in shares of Lumexa Imaging during the fourth quarter valued at about $1,264,000.

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.